日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Polygenic Risk Scores Predicting Estimated GFR Validated With Iohexol Clearance

多基因风险评分预测估算肾小球滤过率,并用碘海醇清除率进行验证

Eriksen, Bjørn O; Kretzler, Matthis; Nair, Viji; Enoksen, Inger T T; Hallan, Stein; Porserud, Jon V N; Rinde, Ludvig; Melsom, Toralf

Use of the VELYS Robotic-Assisted Solution in knee arthroplasty: A scoping review

VELYS机器人辅助解决方案在膝关节置换术中的应用:一项范围界定综述

Morrison, Scott R; Hall, Andrew J; Clement, Nick D; Walmsley, Phil J; Gee, Christopher; Clarke, Jon V

High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort

在非糖尿病人群前瞻性队列研究中,高肾小球滤过率(GFR)可预测全因死亡率和心血管疾病。

Eriksen, Bjørn O; Fasiolo, Matteo; Mathisen, Ulla D; Jenssen, Trond G; Norvik, Jon V; Schei, Jørgen; Stefansson, Vidar T N; Melsom, Toralf

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials

奥扎尼莫德治疗复发型多发性硬化症患者的脑萎缩及其与长期残疾和认知功能的关系:来自 3 期和开放标签扩展试验的结果

Cohen, Jeffrey A; Arnold, Douglas L; DeLuca, John; Hartung, Hans-Peter; Kappos, Ludwig; Comi, Giancarlo; Selmaj, Krzysztof; Steinman, Lawrence; Bar-Or, Amit; Montalban, Xavier; Havrdová, Eva K; Sheffield, James K; Pachai, Chahin; Cheng, Chun-Yen; Riolo, Jon V; Cree, Bruce Ac

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial

奥扎尼莫德治疗复发型多发性硬化症的长期安全性和有效性:DAYBREAK开放标签扩展试验的最终分析

Selmaj, Krzysztof W; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Hartung, Hans-Peter; Montalbán, Xavier; Havrdová, Eva K; Sheffield, James K; Krakovich, Anthony; Cheng, Chun-Yen; Riolo, Jon V; Pachai, Chahin; Thorpe, Andrew; DeBoer, Erik; Kappos, Ludwig; Cohen, Jeffrey A; Cree, Bruce Ac

Are Current Patient-Reported Outcome Measures Fit for Purpose to Evaluate Unicompartmental Knee Arthroplasty?

目前患者报告结果指标是否适合用于评估单髁膝关节置换术?

Bayram, John M; Clement, Nicholas D; Hall, Andrew J; Walmsley, Phil; Clarke, Jon V

The Clinical Frailty Scale is a valid and independent predictor of one-year survival in patients sustaining a hip fracture : scottish Hip Fracture Audit data from 8,092 patients

临床衰弱量表是髋部骨折患者一年生存率的有效且独立的预测指标:苏格兰髋部骨折审计数据(来自 8,092 名患者)

Kennedy, Matthew J; Penfold, Rose S; Donaldson, Lorraine; Hall, Andrew J; Davison, Martin J; MacLullich, Alasdair M J; Walmsley, Phil; Clement, Nick D; Clarke, Jon V

Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial

在开放标签扩展 DAYBREAK 试验中,对复发性多发性硬化症患者同时使用血清素能抗抑郁药和奥扎尼莫德进行治疗。

Naismith, Robert T; Cohen, Jeffrey A; Bar-Or, Amit; Comi, Giancarlo; Selmaj, Krzysztof W; Hartung, Hans-Peter; Sheffield, James K; Krakovich, Anthony; Tatosian, Daniel; Cheng, Chun-Yen; Reardon, Jennifer; Khaychuk, Vadim; Riolo, Jon V; Silva, Diego; Cree, Bruce Ac

Biogenesis of mitochondrial β-barrel membrane proteins

线粒体β桶状膜蛋白的生物合成

Ganesan, Iniyan; Busto, Jon V; Pfanner, Nikolaus; Wiedemann, Nils

Validation of eGFR for Detecting Associations Between Serum Protein Biomarkers and Subsequent GFR Decline

验证eGFR在检测血清蛋白生物标志物与后续GFR下降之间关联性方面的有效性

Enoksen, Inger T T; Rinde, Nikoline B; Svistounov, Dmitri; Norvik, Jon V; Solbu, Marit D; Eriksen, Bjørn O; Melsom, Toralf